HEALTHSTAT NEWS
STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversight
A secret shopper study revealed that telehealth sites prescribing GLP-1 medications for weight loss often operate with minimal clinical oversight, enabling fast and easy access to drugs like semaglutide and tirzepatide. The study, conducted by a Yale researcher and published in the Journal of the American Medical Association, highlights concerns about virtual care practices and the market for non-FDA-approved compounded versions due to shortages.
Mentioned
Related Signal
Adjacent reporting
- Weight-loss drugs like GLP-1s are easy to buy online, raising overdose and safety concerns
- Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight
- GLP-1 Users Turn to Telehealth to Access Weight Loss Drugs
- How an experimental weight-loss drug is being openly promoted by physicians